OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition
Hunter Covert,1 Liliana F Mellor,2,3 Cody L Wolf,1 Nicole Ankenbrandt,1 Jacqueline M Emathinger,2 Ken Tawara,1 Julie Thom Oxford,1,2 Cheryl L Jorcyk1,21Boise State University, Biomolecular Sciences Program, Boise, ID 83725, USA; 2Boise State University, Department of Biological Sciences, Boise, ID 8...
Main Authors: | Covert H, Mellor LF, Wolf CL, Ankenbrandt N, Emathinger JM, Tawara K, Oxford JT, Jorcyk CL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/osm-induced-cd44-contributes-to-breast-cancer-metastatic-potential-thr-peer-reviewed-article-CMAR |
Similar Items
-
OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung
by: Ken Tawara, et al.
Published: (2018-06-01) -
Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage
by: M Durigova, et al.
Published: (2011-01-01) -
Molecular Simulation of Oncostatin M and Receptor (OSM–OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease
by: Qingqing Du, et al.
Published: (2020-03-01) -
The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
by: Andrea Abaurrea, et al.
Published: (2021-08-01) -
The role of CD44 in epithelial–mesenchymal transition and cancer development
by: Xu HX, et al.
Published: (2015-12-01)